Plandai Biotechnology Inc (PLPL)

[Baris]

Must Read $TXTM DD- The Setup for Worldwide Monopoly

Please indulge me here as we endeavor upon what exactly may have transpired here that has positioned TXTM to become a major MMJ company internationally.

LETS START WITH THE MOST RECENT PRESS RELEASE Announcing the 8K news

BOCA RATON, FL--(Marketwired - January 10, 2017) - Plandaí Biotechnology, Inc. (OTC PINK: PLPL) ("Plandaí" or "the Company"), producer of the highly bioavailable Phytofare® catechin complex, today announced that it has completed a share exchange between Plandaí Biotechnology South Africa (PTY) LTD "Plandaí SA," and Protext Mobility, Inc. (OTC PINK: TXTM) "Protext", a Delaware company. Under the terms of the Exchange Agreement, Plandaí became the majority owner of Protext with Plandaí SA becoming the successor issuer to Protect for reporting and accounting purposes. It is anticipated that the prior operations and assets of Protext will be liquidated in the coming weeks, leaving Plandaí SA as the surviving operating entity.

PLEASE UNDERSTAND THAT THIS IS ACTUALLY VERY SIGNIFICANT:

PLPL - otherwise known as Plandai or Plandai Biotechnology BECAME THE MAJORITY OWNER of TXTM

LETS BETTER UNDERSTAND THEN WHY THIS DEAL IS MUCH BIGGER THAN WE REALIZED:

IMO, In order to do this, we need to take a closer look at PLPL and what they have been doing the past 3 years IN PREPARATION for the 2/1/17 legalization of Medical MJ in South Africa.

2014 is a very monumental year in understanding the signifncance here:

PLPL - Plandai Biotechnology, Inc established its subsidiary Plandai SA, in 2014, to provide a platform for expanding the research of Plandaí's proprietary Phytofare® extracts into pharmaceutical application and then obtaining product claims.

FROM 2014-2015 NEWS:
Plandaí SA has the exclusive license and rights to develop, manufacture, and sell all current and future Phytofare® extracts for the pharmaceutical market worldwide. The first targeted product will focus on treating diabetes by regulating blood sugar levels with an expectation of being market ready by the latter half of 2017.
Plandaí SA will operate with distinct management concentrating on pharmaceutical applications and obtaining drug and structure-function claims
Plandaí SA will produce a finished product targeting a specific application, such as managing glucose levels in diabetics."

NOW THIS IS WHERE IT GETS VERY EXCITING IMO :

CHECK THIS OUT:

IN 2014- PLPL also created this subsidiary CANNABIS BIOSCIENCES,INC

PLPL, The Company, is actively pursuing research on additional botanical extracts that have known or suspected pharmaceutical properties. This research includes developing a non-psychoactive cannabinoid extract through the Company’s wholly-owned subsidiary, Cannabis Biosciences, Inc. This company has concluded its investigative research on cannabis and developed a method of extraction which it believes can produce a complete cannabis complex in a highly bioavailable format but without psychoactive effects. The Company obtained a license in Uruguay that will permit it to produce its cannabinoid extract and conduct laboratory research on live cannabis plant. Provided that the company can produce such an extract, the plan is to commence animal research on neural disorders such as Parkinson’s, Alzheimer’s, MS, epilepsy, and post-concussion syndrome in order to determine definitively if cannabis possesses medicinal properties meriting further human trials.

SO AS THIS IS ALL GOING ON....look what appears to be going on over in South Africa in 2014!!



READ The DD here : :

THEN THEY ANNOUNCED THIS NEWS AFFECTING SOUTH AFRICA

Plandai Biotechnology Inc (OTCMKTS:PLPL) will be offering its expertise to draft a legislation which will facilitate and guide legalization of marijuana for medical purposes in South Africa. The company will take services of the South African law firm, Werksmans Attorneys, (LEX Africa) Sandton who also specialize in health law, to help them draft and file comments on the bill.

The bill if passed will legalize usage of marijuana for medical purpose and eventually allow companies in the region to conduct medical research on the same. The bill was introduced this February in the South African Assembly and the bill’s primary objective is to set up more research hospitals especially relating the area where treatment and cure of cancer is researched. Under the current law, medical practioners are legally denied to prescribe cannabis and other proven harmless and effective medication.

THIS BILL, Which went through and PASSED in South Africa in late 2016, with a few changes that eliminated recreational and commercial marijuana from legality. THIS LAW, IN EFFECT, allows for the medical marijuana research and exploration and well as the beginning of application of MMJ to patients. Now guess who holds the worldwide license that is fully effectuated here for South Africa?


SO WHAT DOES THAT NOW MEAN FOR SOUTH AFRICA AND PLPL South Africa/TXTM?

Well check this out, Plandai Biotechnology, via Advocate Stransham-Ford approached the traditional leaders in 2014 to negotiate deals for growing Cannabis in the sovereign lands of South Africa, where for decades, peoples’ crops have been destroyed and sprayed by the SAPS Air Wing Unit. These deals were concluded.

THEY COMPLETED THESE DEALS FOLKS!

AND PLPL South Africa expansion GREATLY benefits the UNITED STATES Government financially, since they own the PATENT on cannabanoids since 2003. :

CHECK IT --->>>. Plandai Biotechnology has to operate under license to the U.S. government who have owned the “worldwide patent on cannabinoids” since 2003. Now, although this is unnatural, unconstitutional and a violation of every civil liberty known to man, they have legislated this into effect worldwide through International treaties such as the UNSCND.


SO ACCORDING TO SAACRA - a medical marijuana activist group in South Africa: Pladai has written the laws on medical marijuana in South .afircs, worked with the politicians and doctors to get it into legislation and worked with attorneys to get it approved :



YOU MUST READ THIS AGAIN... 6,000,000,000,000 per annum and TXTM has monopoly:

Even if cannabis is eventually made available to South Africans in smoked form, you will have to pay a manipulated and controlled price for what you can grow for free. This company Plandai, and to a lesser extent its subsidiary licensees, will be the sole beneficiary of all proceeds of the Cannabis industry in South Africa.
The cannabis industry is estimated to be worth $6 000 000 000 000 per annum.
Shared in an equitable, free market in South Africa via micro, cottage, small, medium and large businesses, implemented via Agricultural, Industrial, Medicinal, and Domestic Skills Development Models, that has the capacity to eliminate poverty and all its associated societal ills.

MORE DD and pictures to prove everything stated above :

For its part, the Plandaí subsidiary, Cannabis Biosciences, Inc., will be developing and testing a botanical extract derived from cannabis, and the company its marijuana research will address neural disorders with. Specifically, the company believes that the phytonutrients in cannabis show excellent potential for treating and preventing a host of neuron and injury related brain diseases including Parkinson's, Alzheimer's, ALS, MS, epilepsy, PTSD and post-concussion syndrome.
Plandaí expects to use its licensed Phytofare™ and Pheroid™ technologies to produce an FDA approved Phytofare™ cannabinoid complex that can address neural disorders without introducing the psychoactive element of THC to its treatments. Plandaí's extraction and hydrodynamic sheering process combined with its Pheroid™ technology, should allow it to produce an extract that captures and enhances the phytocannabinoids while omitting the psychotropic effects associated with metabolized THC.


PLPL South Africa NOW $TXTM ---- TEAMING UP WITH TOP SOUTH AFRICAN UNIVERSITIES TO CONDUCT RESEARCH

Plandaí’s live-plant extraction process recovers phytonutrients from plant material in a mainly nano particle form and rearranges the antioxidants (polyenes) into a format bio-compatible with humans and animals. In addition, through Plandaí’s agreement with North West University, South Africa, the company holds the world license to the Pheroid® patented entrapment system to deliver protected Phytofare™ antioxidants to the white blood cells.”
It is now common knowledge that all the medicine of cannabis is perfectly bio-available in raw form in the mature flowers of the plant, which can be eaten, juiced, smoked or cooked into food.
It is now also common knowledge that this medicine is moreover perfectly easy to extract in a domestic setting for the minimal cost of the carrier oil where you grow your own plants. These plants are perfectly suited to thrive in South African conditions with barely any supervision or attention. If we so choose, of course…

THUS---- PLPL/TXTM has cornered the market already in South Africa and with legalization set for FEB 1, 2017- look at some of the other MMJ activists speaking out against the MONOPOLY that $TXTM now has!



HERE IS The PLPL/TXTM FACILITY/Laboratory now completed built and ready for continued research and production.

http://investorshub.advfn.com/uimage/uploads/2017/1/25/phidvimage.jpeg


OTHER CROPS Like tea leaves already growing to perfection


http://investorshub.advfn.com/uimage/uploads/2017/1/25/rmutzimage.jpeg


SUPPORT FROM SOUTH AFRICAN MMJ COMMUNITY for PLPL South Africa seen here


http://investorshub.advfn.com/uimage/uploads/2017/1/25/ytixvimage.png


http://investorshub.advfn.com/uimage/uploads/2017/1/25/puenhimage.png